Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Markus S. Anker"'
Autor:
Lars Michel, Stefanie Jehn, Iryna Dykun, Markus S. Anker, Peter Ferdinandy, Dobromir Dobrev, Tienush Rassaf, Amir A. Mahabadi, Matthias Totzeck
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 52, Iss , Pp 101419- (2024)
Background: Cardiac troponin I (cTnI) above the 99th percentile is associated with an increased risk of major adverse events. Patients with detectable cTnI below the 99th percentile are a heterogeneous group with a less well-defined risk profile. The
Externí odkaz:
https://doaj.org/article/ac8efc9d3649454583bc0021fb01ddbe
Autor:
Ruben Evertz, Christine Diehl, Katharina Gödde, Miroslava Valentova, Tania Garfias-Veitl, Tobias R. Overbeck, Friederike Braulke, Alessia Lena, Sara Hadzibegovic, Annalen Bleckmann, Ulrich Keller, Ulf Landmesser, Alexander O. König, Gerd Hasenfuss, Andreas Schuster, Markus S. Anker, Stephan von Haehling
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Maintaining cancer patients’ exercise capacity and therefore patients’ ability to live a self-determined life is of huge importance, but little is known about major determinants. We sought to identify determinants of exercise capacity in
Externí odkaz:
https://doaj.org/article/714f73e5313b4f03983b1731284c9e65
Autor:
Markus S. Anker, Alessia Lena, Eric J. Roeland, Jan Porthun, Sebastian Schmitz, Sara Hadzibegovic, Philipp Sikorski, Ursula Wilkenshoff, Ann‐Kathrin Fröhlich, Luisa Valentina Ramer, Matthias Rose, Jan Eucker, Tienush Rassaf, Matthias Totzeck, Lorenz H. Lehmann, Stephan vonHaehling, Andrew J.S. Coats, Tim Friede, Javed Butler, Stefan D. Anker, Hanno Riess, Ulf Landmesser, Lars Bullinger, Ulrich Keller, Johann Ahn
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 4, Pp 1670-1681 (2023)
Abstract Background Maintaining the ability to perform self‐care is a critical goal in patients with cancer. We assessed whether the patient‐reported ability to walk 4 m and wash oneself predict survival in patients with pre‐terminal cancer. Me
Externí odkaz:
https://doaj.org/article/82004b66f10346b7a6c7d5d527c6beba
Autor:
Sara Hadzibegovic, Jan Porthun, Alessia Lena, Pia Weinländer, Laura C. Lück, Sophia K. Potthoff, Lukas Rösnick, Ann‐Kathrin Fröhlich, Luisa Valentina Ramer, Frederike Sonntag, Ursula Wilkenshoff, Johann Ahn, Ulrich Keller, Lars Bullinger, Amir A. Mahabadi, Matthias Totzeck, Tienush Rassaf, Stephan vonHaehling, Andrew J.S. Coats, Stefan D. Anker, Eric J. Roeland, Ulf Landmesser, Markus S. Anker
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 4, Pp 1682-1694 (2023)
Abstract Background Hand grip strength (HGS) is a widely used functional test for the assessment of strength and functional status in patients with cancer, in particular with cancer cachexia. The aim was to prospectively evaluate the prognostic value
Externí odkaz:
https://doaj.org/article/692c182a9e8543e5a40a59b1334c501b
Autor:
Luping Yuan, Jochen Springer, Sandra Palus, Silvia Busquets, Queralt Jové, Edson Alves de Lima Junior, Markus S. Anker, Stephan vonHaehling, Natalia Álvarez Ladrón, Oliver Millman, Annemijn Oosterlee, Agata Szymczyk, Francisco Javier López‐Soriano, Stefan D. Anker, Andrew J.S. Coats, Josep M. Argiles
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 1, Pp 653-660 (2023)
Abstract Background Beta‐blockers and selected stereoisomers of beta‐blockers, like bisoprolol and S‐pindolol (ACM‐001), have been shown to be effective in preclinical cancer cachexia models. Here, we tested the efficacy of stereoisomers of o
Externí odkaz:
https://doaj.org/article/748d4538c7ce45089201c07ab020fbb6
Autor:
Ruben Evertz, Katharina Gödde, Christine Diehl, Miroslava Valentova, Tania Garfias‐Veitl, Friederike Braulke, Gerald G. Wulf, Tobias R. Overbeck, Annalen Bleckmann, Alexander O. König, Pia Weinländer, Sophia Potthoff, Sara Hadzibegovic, Alessia Lena, Ulrich Keller, Ulf Landmesser, Andreas Schuster, Markus S. Anker, Gerd Hasenfuß, Stephan vonHaehling
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 167-176 (2023)
Abstract Aims Maintaining quality of life (QoL) in patients with cancer has gathered significant interest, but little is known about its major determinants. We sought to identify determinants of QoL in patients undergoing cancer treatment as well as
Externí odkaz:
https://doaj.org/article/586093e844e2498bae29c65f7e2a7ebf
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 6, Pp 2763-2771 (2022)
Externí odkaz:
https://doaj.org/article/c94437583af143859cfe13970df4eb93
Autor:
Karl J. Weiss, Sarah B. Nasser, Tamar Bigvava, Adelina Doltra, Bernhard Schnackenburg, Alexander Berger, Markus S. Anker, Christian Stehning, Patrick Doeblin, Mohamed Abdelmeguid, Mohamed Talat, Rolf Gebker, Wael E‐Naggar, Burkert Pieske, Sebastian Kelle
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 110-121 (2022)
Abstract Aims Although the prevalence of coronary artery disease (CAD) is high among patients with atrial fibrillation (AF), studies on stress perfusion cardiac magnetic resonance (CMR) imaging frequently exclude patients with AF, and its prognostic
Externí odkaz:
https://doaj.org/article/40a447c265554de19bd0bcbb7bf7fe50
Autor:
Ann‐Kathrin Fröhlich, Monika Diek, Corinna Denecke, Stephan vonHaehling, Sara Hadzibegovic, Markus S. Anker
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 6, Pp 1359-1367 (2021)
Externí odkaz:
https://doaj.org/article/a31c92c8f44b45a985b33f27e3bed255
Autor:
Lorenzo Stretti, Dauphine Zippo, Andrew J.S. Coats, Markus S. Anker, Stephan vonHaehling, Marco Metra, Daniela Tomasoni
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4370-4393 (2021)
Abstract Major changes have occurred in these last years in heart failure (HF) management. Landmark trials and the 2021 European Society of Cardiology guidelines for the diagnosis and treatment of HF have established four classes of drugs for treatme
Externí odkaz:
https://doaj.org/article/6eef76e43ba248a29a9273bcbb4bea52